Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

• Vicky C. Chang,
• Ali A. Khan,
• Wen-Yi Huang,
• Hormuzd A. Katki,
• Mark P. Purdue,
• Ola Landgren,
• Jonathan N. Hofmann

Affiliations

Vicky C. Chang

Division of Cancer Epidemiology and Genetics, National Cancer Institute

Ali A. Khan

Division of Cancer Epidemiology and Genetics, National Cancer Institute

Wen-Yi Huang

Division of Cancer Epidemiology and Genetics, National Cancer Institute

Hormuzd A. Katki

Division of Cancer Epidemiology and Genetics, National Cancer Institute

Mark P. Purdue

Division of Cancer Epidemiology and Genetics, National Cancer Institute

Ola Landgren

Myeloma Program, Sylvester Comprehensive Cancer Center, University of Miami

Jonathan N. Hofmann

Division of Cancer Epidemiology and Genetics, National Cancer Institute